Organogenesis Holdings Inc. · NASDAQ:ORGO
Soleus Capital Master Fund, L.P. reported a 9.90% stake in Organogenesis Holdings Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 11, 2025
Soleus Capital Master Fund, L.P. reported a 9.90% stake in Organogenesis Holdings Inc., 12,484,876 shares, as a passive investor on Dec 31, 2024. Filed Feb 11, 2025 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 12,484,876
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus Capital Master Fund, L.P. | 9.90% | 12,484,876 |
| Soleus Capital, LLC | 9.90% | 12,484,876 |
| Soleus Capital Group, LLC | 9.90% | 12,484,876 |
| Soleus Capital Management, L.P. | 9.90% | 12,484,876 |
| Soleus GP LLC | 9.90% | 12,484,876 |
| Guy Levy | 9.90% | 12,484,876 |
Source
Related
- Organogenesis Holdings Inc.
- Soleus Capital Master Fund, L.P.
- Organogenesis Holdings Inc. shareholders
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Feb 12, 2026
- Form 4 · Grow Brian · Apr 24, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Feb 17, 2026
- Schedule 13D/A · Glenn H. Nussdorf · Nov 3, 2025
- Schedule 13G · First Light Asset Management, LLC · Aug 14, 2025
- Schedule 13D/A · Alan A. Ades · Jun 26, 2025